|
1
|
Wan DS: Epidemiologic trend of and
strategies for colorectal cancer. Ai Zheng. 28:897–902. 2009.(In
Chinese). PubMed/NCBI
|
|
2
|
Mandel JS, Church TR, Bond JH, Ederer F,
Geisser MS, Mongin SJ, Snover DC and Schuman LM: The effect of
fecal occult-blood screening on the incidence of colorectal cancer.
N Engl J Med. 343:1603–1607. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kronborg O, Fenger C, Olsen J, Jørgensen
OD and Søndergaard O: Randomised study of screening for colorectal
cancer with faecal-occult-blood test. Lancet. 348:1467–1471. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hardcastle JD, Chamberlain JO, Robinson
MH, Moss SM, Amar SS, Balfour TW, James PD and Mangham CM:
Randomised controlled trial of faecal-occult-blood screening for
colorectal cancer. Lancet. 348:1472–1477. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mandel JS, Bond JH, Church TR, Snover DC,
Bradley GM, Schuman LM and Ederer F: Reducing mortality from
colorectal cancer by screening for fecal occult blood. Minnesota
Colon Cancer Control Study. N Engl J Med. 328:1365–1371. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Imperiale TF, Ransohoff DF, Itzkowitz SH,
Turnbull BA and Ross MEColorectal Cancer Study Group: Fecal DNA
versus fecal occult blood for colorectal-cancer screening in an
average-risk population. N Engl J Med. 351:2704–2714. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rozen P, Levi Z, Hazazi R, Waked A, Vilkin
A, Maoz E, Birkenfeld S and Niv Y: Quantitative colonoscopic
evaluation of relative efficiencies of an immunochemical faecal
occult blood test and a sensitive guaiac test for detecting
significant colorectal neoplasms. Aliment Pharmacol Ther.
29:450–457. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saito H, Soma Y, Nakajima M, Koeda J,
Kawaguchi H, Kakizaki R, Chiba R, Aisawa T and Munakata A: A
case-control study evaluating occult blood screening for colorectal
cancer with hemoccult test and an immunochemical hemagglutination
test. Oncol Rep. 7:815–819. 2000.PubMed/NCBI
|
|
9
|
Saito H: Screening for colorectal cancer:
Current status in Japan. Dis Colon Rectum. 43 (Suppl):S78–S84.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Imperiale TF, Glowinski EA, Lin-Cooper C,
Larkin GN, Rogge JD and Ransohoff DF: Five-year risk of colorectal
neoplasia after negative screening colonoscopy. N Engl J Med.
359:1218–1224. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baxter NN, Goldwasser MA, Paszat LF,
Saskin R, Urbach DR and Rabeneck L: Association of colonoscopy and
death from colorectal cancer. Ann Intern Med. 150:1–8. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kahi CJ, Imperiale TF, Juliar BE and Rex
DK: Effect of screening colonoscopy on colorectal cancer incidence
and mortality. Clin Gastroenterol Hepatol. 7:770–775; quiz.
7112009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brenner H, Haug U, Arndt V, Stegmaier C,
Altenhofen L and Hoffmeister M: Low risk of colorectal cancer and
advanced adenomas more than 10 years after negative colonoscopy.
Gastroenterology. 138:870–876. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brenner H, Chang-Claude J, Seiler CM and
Hoffmeister M: Long-term risk of colorectal cancer after negative
colonoscopy. J Clin Oncol. 29:3761–3767. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brenner H, Chang-Claude J, Seiler CM,
Rickert A and Hoffmeister M: Protection from colorectal cancer
after colonoscopy: A population-based, case-control study. Ann
Intern Med. 154:22–30. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Quintero E, Castells A, Bujanda L,
Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD,
Hernández C, et al: Role: COLONPREV Study InvestigatorsColonoscopy
versus fecal immunochemical testing in colorectal-cancer screening.
N Engl J Med. 366:697–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishihara R, Wu K, Lochhead P, Morikawa T,
Liao X, Qian ZR, Inamura K, Kim SA, Kuchiba A, Yamauchi M, et al:
Long-term colorectal-cancer incidence and mortality after lower
endoscopy. N Engl J Med. 369:1095–1105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Participants in the Paris Workshop, . The
Paris endoscopic classification of superficial neoplastic lesions:
esophagus, stomach, and colon: November 30 to December 1, 2002.
Gastrointest Endosc. 58 (Suppl):S3–S43. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kudo S, Hirota S, Nakajima T, Hosobe S,
Kusaka H, Kobayashi T, Himori M and Yagyuu A: Colorectal tumours
and pit pattern. J Clin Pathol. 47:880–885. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kudo S, Rubio CA, Teixeira CR, Kashida H
and Kogure E: Pit pattern in colorectal neoplasia: Endoscopic
magnifying view. Endoscopy. 33:367–373. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kashida H and Kudo SE: Early colorectal
cancer: Concept, diagnosis, and management. Int J Clin Oncol.
11:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang Q, Fukami N, Kashida H, Takeuchi T,
Kogure E, Kurahashi T, Stahl E, Kudo Y, Kimata H and Kudo SE:
Interobserver and intra-observer consistency in the endoscopic
assessment of colonic pit patterns. Gastrointest Endosc.
60:520–526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kudo S, Tamura S, Nakajima T, Yamano H,
Kusaka H and Watanabe H: Diagnosis of colorectal tumorous lesions
by magnifying endoscopy. Gastrointest Endosc. 44:8–14. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsuruta O, Toyonaga A, Ikeda H, Tanikawa K
and Morimatsu M: Clinicopathological study of superficial-type
invasive carcinoma of the colorectum. Int J Oncol. 10:1003–1008.
1997.PubMed/NCBI
|
|
25
|
van Rossum LG, van Rijn AF, van Oijen MG,
Fockens P, Laheij RJ, Verbeek AL, Jansen JB and Dekker E: False
negative fecal occult blood tests due to delayed sample return in
colorectal cancer screening. Int J Cancer. 125:746–750. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park DI, Ryu S, Kim Y-H, Lee SH, Lee CK,
Eun CS and Han DS: Comparison of guaiac-based and quantitative
immunochemical fecal occult blood testing in a population at
average risk undergoing colorectal cancer screening. Am J
Gastroenterol. 105:2017–2025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakama H, Zhang B and Fattah AS: A
cost-effective analysis of the optimum number of stool specimens
collected for immunochemical occult blood screening for colorectal
cancer. Eur J Cancer. 36:647–650. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bampton PA, Sandford JJ, Cole SR, Smith A,
Morcom J, Cadd B and Young GP: Interval faecal occult blood testing
in a colonoscopy based screening programme detects additional
pathology. Gut. 54:803–806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smith A, Young GP, Cole SR and Bampton P:
Comparison of a brush-sampling fecal immunochemical test for
hemoglobin with a sensitive guaiac-based fecal occult blood test in
detection of colorectal neoplasia. Cancer. 107:2152–2159. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
van Rossum LG, van Rijn AF, Laheij RJ, van
Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB and
Dekker E: Random comparison of guaiac and immunochemical fecal
occult blood tests for colorectal cancer in a screening population.
Gastroenterology. 135:82–90. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lieberman DA, Rex DK, Winawer SJ,
Giardiello FM, Johnson DA and Levin TRUnited States Multi-Society
Task Force on Colorectal Cancer: Guidelines for colonoscopy
surveillance after screening and polypectomy: A consensus update by
the US Multi-Society Task Force on Colorectal Cancer.
Gastroenterology. 143:844–857. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jass JR: Hyperplastic-like polyps as
precursors of microsatellite-unstable colorectal cancer. Am J Clin
Pathol. 119:773–775. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lambert R, Kudo SE, Vieth M, Allen JI,
Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, et al:
Pragmatic classification of superficial neoplastic colorectal
lesions. Gastrointest Endosc. 70:1182–1199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Castiglione G, Grazzini G, Miccinesi G,
Rubeca T, Sani C, Turco P and Zappa M: Basic variables at different
positivity thresholds of a quantitative immunochemical test for
faecal occult blood. J Med Screen. 9:99–103. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morikawa T, Kato J, Yamaji Y, Wada R,
Mitsushima T, Sakaguchi K and Shiratori Y: Sensitivity of
immunochemical fecal occult blood test to small colorectal
adenomas. Am J Gastroenterol. 102:2259–2264. 2007. View Article : Google Scholar : PubMed/NCBI
|
